Policy Briefs
A current record of standing for ACT on issues impacting the health and well-being of people living with HIV and AIDS and those at increased risk of HIV.
ACT Policy Briefs
Below are ACT’s policy briefs. These tackle a single issue and articulates ACT’s viewpoint around it. Policy briefs exist around issues that impacts and/or is related to the agency’s programs, services, strategic goals, mandate and/or mission.
April 2022 UPDATE: Some policy briefs are currently unavailable, we're sorry for any inconvenience. They'll be back up before you know it!
People who inject drugs are more vulnerable to acquiring hepatitis C and HIV. In Toronto, people who inject drugs have also been dying from overdoses at an increasing rate. Harm reduction distribution and establishing integrated supervised injection services are effective public health tools for reducing the spread of HIV and hepatitis C, and preventing unnecessary deaths from overdoses. For these reasons, ACT fully supports Toronto establishing comprehensive harm reduction services that protect people who inject drugs and affirms their right to healthcare services.
A growing body of evidence demonstrates that people living with HIV who have a sustained undetectable viral load for six months or more have a negligible – meaning so insignificant, small, or unimportant as to not worth being considered – chance of passing on the virus during sex, regardless of whether condoms are used. This applies to all genders and methods of sexual transmission, including vaginal, front hole, anal and oral.
Given this breakthrough, ACT is confident in the use of effective HIV treatment as a reliable form of HIV prevention
Feedback or comments on where ACT stands? Get in touch with ACT’s Communications Coordinator at communications@actoronto.org.
